Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sonothrombolysis: experimental evidence.

Michael Daffertshofer1, Michael G Hennerici

  • 1Department of Neurology, University of Heidelberg, University Hospital Mannheim, Mannheim, Germany.

Frontiers of Neurology and Neuroscience
|February 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk of major vascular events in patients without traditional risk factors after transient ischemic attack or minor ischemic stroke: An international prospective cohort.

European stroke journal·2024
Same author

Outcome of endovascular stroke therapy in a large mandatory stroke-registry.

Neurological research and practice·2023
Same author

Underlying Causes of TIA and Minor Ischemic Stroke and Risk of Major Vascular Events.

JAMA neurology·2023
Same author

Effect of atherosclerosis on 5-year risk of major vascular events in patients with transient ischaemic attack or minor ischaemic stroke: an international prospective cohort study.

The Lancet. Neurology·2023
Same author

Stroke Risk and Antithrombotic Treatment During Follow-up of Patients With Ischemic Stroke and Cortical Superficial Siderosis.

Neurology·2022
Same author

Risk of subsequent disabling or fatal stroke in patients with transient ischaemic attack or minor ischaemic stroke: an international, prospective cohort study.

The Lancet. Neurology·2022

Ultrasound combined with tissue plasminogen activator (tPA) shows promise for enhancing acute ischemic stroke treatment by improving artery reopening. This approach may extend the therapeutic window beyond current limitations.

Area of Science:

  • Neurology
  • Biomedical Engineering
  • Cardiovascular Research

Background:

  • Reopening occluded arteries is crucial for treating hyperacute ischemic stroke.
  • Systemic tissue recombinant plasminogen activator (tPA) has a limited 3-hour window.
  • Intra-arterial thrombolysis extends the window to 6 hours but is invasive and not always effective.

Purpose of the Study:

  • To investigate the efficacy of combining ultrasound with thrombolytic agents for acute ischemic stroke.
  • To determine optimal ultrasound parameters for enhanced sonothrombolysis.
  • To assess the safety profile of therapeutic ultrasound for brain tissue.

Main Methods:

  • Utilizing low-frequency ultrasound (kHz range) to enhance enzymatic thrombolysis.
  • Testing ultrasound-mediated thrombolysis in static and flow models.

Related Experiment Videos

  • Evaluating infarct volume reduction in embolic rat models.
  • Assessing safety parameters including hemorrhage, heating, and blood-brain barrier integrity.

    • Main Results:

    • Ultrasound increased tPA-mediated thrombolysis by up to 20% in static models.
    • Recanalization rates improved from 30% to 90% in flow models with ultrasound.
    • Low-frequency ultrasound (0.6W/cm2) significantly reduced infarct volume in rat models.
    • While animal studies showed no increased bleeding, a clinical study reported secondary hemorrhages; pulsed ultrasound protocols mitigated heating effects.

    Conclusions:

    • Combined ultrasound and thrombolytic therapy is a promising approach for acute ischemic stroke.
    • Optimizing ultrasound frequency, intensity, and pulsing protocols is key for efficacy and safety.
    • Further research is needed to refine sonothrombolysis for clinical application in stroke treatment.